Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Grethel Perez Meek, DO
Articles
Phase 3 Trials Examine Gantenerumab for Early Alzheimer Disease
Meagan Kubista, MD;Grethel Perez Meek, DO;Kyle Sramek, MD;Mark Mullen, MD;Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
February 20th 2024Two phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.
Latest Updated Articles
Published: March 19th 2021 | Updated: December 23rd 2024
Mini Quiz: Treatment for Pedophilia?
Published: December 20th 2024 | Updated: December 23rd 2024
Poll: How Are You Handling the Holidays as a Clinician?
Published: December 18th 2024 | Updated: December 23rd 2024
Criminal Sanctions, Psychosis, and Mortality
Published: January 21st 2016 | Updated: December 23rd 2024
Mini Quiz: Methods of Suicide
Published: May 12th 2017 | Updated: December 23rd 2024
Mini Quiz: Medical Catatonia
Published: April 5th 2017 | Updated: December 23rd 2024
Mini Quiz: Integrative Child Psychiatry
